Hemopericardium with cardiac tamponade after intravenous thrombolysis for acute myocardial infarction

Clinical Cardiology

Volumn 19, Issue 5, 1996, Pages 432-434

  Mohammad, Saeed ^a   Austin, Stephen M ^a  

^a University of Wisconsin Health   (United States)

Author keywords

cardiac tamponade; hemopericardium; myocardial infarction; thrombolytic therapy

Indexed keywords

ANISTREPLASE; HEPARIN; TISSUE PLASMINOGEN ACTIVATOR;

ACUTE HEART INFARCTION; ADULT; AGED; ARTICLE; BLOOD CLOT LYSIS; CASE REPORT; CLINICAL FEATURE; FEMALE; HEART TAMPONADE; HEMOPERICARDIUM; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; PERICARDIOCENTESIS; TRANSLUMINAL CORONARY ANGIOPLASTY;

EID: 0029832463     PISSN: 01609289     EISSN: None     Source Type: Journal    
DOI: 10.1002/clc.4960190520     Document Type: Article

References (13)

1. Gruppo Italiano per lo Studio della Streptochinasi nell' Infarto Miocardico (GISSI): Effectiveness of intravenous thrombolytic treatment in acute myocardial infarction. Lancet 1, 397-402 (1986)
2. ISIS-2 (Second International Study of Infarct Survival) Collaborative Group: Randomized trial of intravenous streptokinase. oral aspirin, both, or neither among 17,187 cases of suspected myocardial infarction: ISIS-2. Lancet 2, 349-360 (1988)
3. Van de Werf F, Arnold AER, and the European Cooperative Study Group for Recombinant Tissue-Type Plasminogen Activator: Intravenous tissue-type plasminogen activator and size of infarct. left ventricular function, and survival in acute myocardial infarction. Br Med J 297, 1374-1379 (1988)
4. Wilcox RG, Von der Lippe G, Olson CG, Jensen G, Skene AM, Hampton JR: Trial of tissue plasminogen activator for mortality reduction in acute myocardial infarction. Anglo-Scandinavian Study of Early Thrombolysis (ASSET). Lancet 2, 525-530 (1988)
5. Bassand J-P, Machecourt J, Cassagnes J, Anguenot T, Lusson R, Borel E, Peycelon P, Wolf E, Ducellier D. for the APSIM Study Investigators: Multicenter trial of intravenous anisoylated plasminogen streptokinase activator complex (APSAC) in acute myocardial infarction: Effects on infarct size and left ventricular function. J Am Coll Cardiol 13, 988-997 (1989)
6. Gruppo Italiano per lo Studio della Sopravvivenza nell' Infarto Miocardico. GISSI-2: A factorial randomized trial of alteplase versus streptokinase and heparin versus no heparin among 12,490 patients with acute myocardial infarction. Lancet 336, 65-71 (1990)
7. ISIS-3 (Third International Study of Infarct Survival) Collaborative Group: ISIS-3: A randomized comparison of streptokinase vs tissue plasminogen activator vs anistreplase and of aspirin plus heparin vs aspirin alone among 41.299 cases of suspected acute myocardial infarction. Lancet 339, 753-770 (1993)
8. The GUSTO Investigators: An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction. N Engl J Med 329, 673-682 (1993)
9. Valeix B, Labrunie P, Jahjah F, Sans P, Malmejac C, Jouven JC, Levy S, Gerard R: Hemopericardium after coronary recanalization by streptokinase during acute myocardial infarction: Drainage and early aortocoronary bypass on fourth day. Arch Mal Coeur 76, 1081-1084 (1983)
10. Walker WE, Fuentes F, Adams PR, Kuykendall RC, Mc Arthur JD, Weiland AP: Hemopericardium and tamponade following intracoronary thrombolysis with streptokinase. Tex Heart Insr J. 12, 203-206 (1985)
11. Giles PJ, D'Cruz IA, Killiam HAW: Tamponade due to hemopericardium after streptokinase therapy for pulmonary embolism. South Med J 81, 912-914 (1988)
12. Barrington WW, Smith JE, Himmelstein SI: Cardiac tamponade following treatment with tissue plasminogen activator: An atypical response to pericardiocentesis. Am Heart 7121, 1227-1229 (1991)
13. Renkin J, De Brune B, Berit E, Joris JM, Carlier M, Col J: Cardiac tamponade early after thrombolysis for acute myocardial infarction: A rare but not reported hemorrhagic complication. J Am Coll Cardiol 17, 280-285 (1991)